Testimonials

Since Tri-Solfen^® was commercially launched, over 150 million lambs have been treated and over 80% of Australian wool growers are now using Tri-Solfen for their sheep. Here’s what some of them have to say…

‘We have used pain relief for two years now and seen real production gains. We are concerned for the welfare of our animals and will continue to use pain relief to ensure they get the best care.’

Clinton Wise– Wililoo Merino Stud, Woodanilling, W.A.

'It easy to see the difference pain relief makes. Before, lambs would walk away hunched up, even taking a couple of hours to walk back to the paddock. Now they run straight back to Mum and start suckling,” says Rod. “My wool is now sold under the Better Choices brand. I see this as a definite advantage. I think it will be an advantage in the long run, to both me and the industry as a whole.'

Rod Miller– Glenpaen Merino Stud, Horsham, Vic

'After being treated with pain relief my lambs were more content and less stressed. As farmers we are sincere in looking after the welfare of our animals and using pain relief demonstrates this.'

Richard Coole– Frankland, W.A.

'We have been using pain relief for the past three years. We’re impressed by reduced bleeding in the mulesing wound immediately after application. Lambs run straight back to find the ewe, which has dramatically reduced our mortality rates. Flock management, post lamb marking is easier due to the effect of pain relief and the scab healing faster.'

Ryan & Malcom O’Dea– Peepingee Merino Stud, Narrogin, W.A.

'Using pain relief eases the stress and allows lambs to mother up and move back to the paddock easier with faster weight gains.'

Kent Lummis– Waverley Downs, Gilgandra, NSW

Country	Species	Patent
Australia	Sheep	Granted
Australia	Horses, Dogs, Lab animals	Granted
Australia	Cattle	Granted
Australia	Humans	Granted
New Zealand	Sheep, Cattle	Granted
New Zealand	Horses, Dogs, Lab animals	Granted
EU	Humans	Granted
EU	Pig, Sheep, Cattle	Granted
USA	Dogs, Horses, Lab animals	Granted
USA	Humans	Granted
USA	Pig, Sheep, Cattle	Granted
Canada	Horses, Dogs, Lab animals	Granted
Canada	Cattle, Pig	Granted
Canada	Humans	Granted

Advisory Board

Ian Page

Non-Executive Director

Ian is Chief Executive Officer of Dechra Pharmaceuticals, which has a 33% shareholder in Medical Ethics. He joined National Veterinary Services, Dechra’s former services business in 1989 and joined the Board of Dechra in 1997. In October 2010, Ian was appointed as Non-Executive Chairman of Sanford DeLand Asset Management.

Dr Chris Roberts

Human Wound and Regulatory Advisor

Chris has over 20 years’ line management experience of heading clinical research teams. He was previously global head of Smith & Nephew clinical support and market development, where he managed global clinical Phase II and III programmes in the management of venous and pressure ulcers.

Lieutenant Colonel Professor Steven Jeffery

Medical Specialist Advisor

Steve has over 15 years’ experience in military plastic surgery. In 2011 he was awarded the Military Civilian Partnership Award for ‘Regular of the Year’, as well as receiving the Wounds UK ‘Key Contribution’ award and the Smith and Nephew ‘Customer Pioneer of the Year’ award. He has also been awarded Fellowship of the Royal College of Surgeons of England ad eundum. He is an expert adviser to NICE Medical Technologies Evaluation Programme. Steve co-founded the Woundcare 4 Heroes charity, which is already making a big difference to the wound care of both serving and veteran personnel.

Dr Matthew Bayfield

Medical Specialist Scientific Director

Dr Matthew Bayfield, Head of Cardiothoracic Surgery, Strathfield Private Hospital and VMO Cardiothoracic Surgeon, Royal Prince Alfred Hospital.

Professor Peter Windsor

Veterinarian Research Advisor

Peter is a registered specialist veterinary surgeon in New South Wales and an emeritus Professor at Sydney University. He holds a BVSc (Hons), PhD, DVSc and diploma from the European College of Small Ruminant Health Management.

Dr Julian Braidwood

Global Regulatory Affairs Advisor

Julian has held leadership roles and managed international clinical projects with Grampian. He was previously Regulatory Affairs Manager at Novartis Animal Health. He is the Founder and Managing Director of Triveritas, where he is responsible for a team of 40 animal health specialists across the EU and the US.

Tri–Solfen^®

Tri-Solfen^® is a local anaesthetic and antiseptic gel spray that adheres well to wounds and acts as a barrier to environmental stimuli, promotes haemostasis and improves wound healing. Tri-Solfen^® contains two proven topical local anaesthetics; fast-acting Lignocaine for immediate pain relief and long-acting bupivacaine for prolonged post-operative pain relief. Adrenaline is included for its ability to reduce the shock and stress of blood loss, whilst prolonging the anaesthetic action. Tri-Solfen^® also contains Cetrimide; an antiseptic widely used to cleanse skin and wounds and provides protection from bacterial contamination.

Animals

World 1st

There is an urgent need for fast-acting, practical to use, pain mitigation and accelerated wound healing products, for use during animal surgical procedures.

Globally, over one billion farm animals undergo highly invasive painful surgical procedures annually (castration, dehorning, tail docking)
Billions of farm animals also undergo less invasive procedures such as de-beaking in chickens
Tens of millions of animals suffer from leg and shoulder ulcers, foot abscesses, accidental wounds and painful skin irritations
Currently, a large majority of procedures are performed by a vet or farmer without analgesics
The global number of livestock in 2017 was 26 billion, this is expected to reach 39 billion by 2030
There is global pressure, supported by governments and non-governmental organisations, to provide pain relief alongside surgical procedures on animals

We are the first, and currently the only, company globally to develop, launch and commercialise a topical pain and wound management product for use in livestock undergoing painful husbandry procedures – Tri-Solfen^® is recognised as the only safe, practical and efficient product for use on such wounds.

Winner of the Animal Pharm ‘Best New Food Animal Product’. Click to read more.

Development and application

Our product is successfully being used to improve animal welfare

Since launch, Tri-Solfen^® has been used to successfully treat over 150 million animals undergoing routine surgeries in the Australian livestock industries.

2004, Tri-Solfen^® developed by Dr Meredith Sheil, Medical Ethics’ Chief Technical Officer
2005, Tri-Solfen^® approved for use in sheep in Australia
2006, Tri-Solfen^® launched in Australia by Bayer Animal Health
2013, Tri-Solfen^® granted over-the-counter status expanding the potential distribution
2014, Tri-Solfen^® approved for use in cattle in Australia
2017, commercial partnership with Dechra Pharmaceuticals to support the registration of Tri-Solfen^® globally (excluding Australia and New Zealand)
2017, Tri-Solfen^® approved for use in sheep and cattle in New Zealand

Future opportunities

We are committed to continuing to deliver Tri-Solfen^®, as a highly effective, safe, affordable and practical pain relief product, to prevent pain and minimise suffering associated with wounds in livestock and companion animals.

Future opportunities in animals include:

Continue to secure global registrations for Tri-Solfen^® in livestock surgical procedures
Companion animals (traumatic wounds)
- Accidental trauma
- Injury
- Laceration
- Animal emergency rescue
Companion animals (surgical wounds)
- Sterilisation
- Injury
- Illness / disease
- Laboratory setting

Email alerts